I posted this earlier. #2 which is what you are referring to has very high barriers of entry and will eventually be absorbed by #4 in my opinion and the FDA will have full jurisdiction and the barriers of entry will be a sunk cost and all will have to be resubmitted to the FDA.
its important to notate now 4 different sub sectors in the USA developing for the sale of actual cannabis products: 1. Recreational Marijuana in individual states 2. Medical Marijuana in individual states 3. CBD Oil from Agricultural Hemp 4. Pharmaceutical
Keep in mind #3 and #4 are national plays. CVSI is working on both. They are going to go wherever the market allows them to go.